StonvexLoading…
StonvexStonvexStonvexCore line items from AREN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $134.83M | $125.91M | $143.63M | $220.94M |
Operating Income | $40.79M | $7.87M | $-17.46M | $-55.88M |
Net Income | $124.86M | $-100.71M | $-55.58M | $-70.86M |
EPS (Diluted) | $2.62 | $-2.85 | $-2.49 | $-4.02 |
Total Assets | $112.60M | $116.35M | $188.88M | $203.72M |
Total Liabilities | $117.43M | $246.51M | $247.71M | $242.69M |
Cash & Equivalents | $10.34M | $4.36M | $9.28M | $13.87M |
Free Cash Flow OCF − CapEx | $39.25M | $-16.13M | Not available | $-11.83M |
Shares Outstanding | 47.59M | 47.56M | 23.84M | 18.30M |